A discrepancy in supply and demand because of quota restrictions has left thousands of people unable to obtain medications for attention-deficit/hyperactivity disorder. "It's more frustrating than I can actually articulate. This should not be happening in America," said Trish Luberda of Pennsylvania, mother of two daughters with the disorder.

Related Summaries